Udumula, M.P.; Poisson, L.M.; Dutta, I.; Tiwari, N.; Kim, S.; Chinna-Shankar, J.; Allo, G.; Sakr, S.; Hijaz, M.; Munkarah, A.R.;
et al. Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo. Cancers 2022, 14, 1504.
https://doi.org/10.3390/cancers14061504
AMA Style
Udumula MP, Poisson LM, Dutta I, Tiwari N, Kim S, Chinna-Shankar J, Allo G, Sakr S, Hijaz M, Munkarah AR,
et al. Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo. Cancers. 2022; 14(6):1504.
https://doi.org/10.3390/cancers14061504
Chicago/Turabian Style
Udumula, Mary P., Laila M. Poisson, Indrani Dutta, Nivedita Tiwari, Seongho Kim, Jasdeep Chinna-Shankar, Ghassan Allo, Sharif Sakr, Miriana Hijaz, Adnan R. Munkarah,
and et al. 2022. "Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo" Cancers 14, no. 6: 1504.
https://doi.org/10.3390/cancers14061504
APA Style
Udumula, M. P., Poisson, L. M., Dutta, I., Tiwari, N., Kim, S., Chinna-Shankar, J., Allo, G., Sakr, S., Hijaz, M., Munkarah, A. R., Giri, S., & Rattan, R.
(2022). Divergent Metabolic Effects of Metformin Merge to Enhance Eicosapentaenoic Acid Metabolism and Inhibit Ovarian Cancer In Vivo. Cancers, 14(6), 1504.
https://doi.org/10.3390/cancers14061504